Interferon Therapy

Treatment Increases Autoantibodies in Some HCV Patients

Published in Hepatitis Weekly, September 25th, 2000

According to researchers at the University of Padua in Italy, a small percentage of hepatitis C virus (HCV) patients will have increased autoantibodies for cells and hormones produced in the pancreas or the thyroid following interferon (IFN) therapy.

Some previous reports have indicated an increased incidence of autoimmune diseases in HCV patients. The goal of C. Betterle and colleagues was to determine whether HCV patients in Italy would have a higher prevalence of autoimmune diseases or autoantibodies following treatment with IFN-alpha.

Seventy patients with chronic HCV were selected to participate in the research project. Many tests were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry